IFAIN's research programme spans funded multi-site studies, surveillance systems, and laboratory investigations — generating locally grounded evidence with direct implications for Nigeria's infectious disease burden.
● Active Studies
The International Foundation Against Infectious Disease in Nigeria (IFAIN), in collaboration with the Global Vaccine Data Network (GVDN), has launched the Background Rates of Adverse Events for Vaccine Evaluation in Africa (BRAVE) project in Nigeria, with additional implementation in Ghana, Rwanda, and Kenya.
Officially kicked off at the Abubakar Tafawa Balewa University Teaching Hospital (ATBUTH) in Bauchi, the project aims to establish baseline incidence rates of key health conditions across four Nigerian sites—namely FMC Owo, Irrua Specialist Teaching Hospital, University of Benin Teaching Hospital, and ATBUTH, which serves as the lead implementation hub.
Over a three-year core implementation period, the project will gather pre-vaccine data. This will be followed by an additional two years of surveillance, making a total span of five years . Data will be collected from patients admitted in pediatrics, obstetrics & gynecology, and internal medicine departments, using a pre-defined list of priority conditions.
A key focus is to prepare for the rollout of Lassa fever vaccines, ensuring that once introduced, any deviations from baseline health data can be confidently assessed as vaccine‑related or incidental.
Beyond surveillance, BRAVE aims to strengthen Nigeria’s healthcare framework by building health worker capacity and improving data infrastructure—a strategic step toward advancing the country’s readiness for future vaccine and drug trials.
Africa led transformation of public health approach to controlling high burden respiratory pathogens and AMR through vaccine based multi modal interdisciplinary interventions.
The CAMRA project is a comprehensive field-to-laboratory investigation of Nigerian and Rwandan children with serious bacterial infections (SBI). It aims to characterize the distribution and determinants of antimicrobial resistance (AMR) among Enterobacterales and the diseases they cause by prospectively enrolling hospitalized newborns, infants, and children with severe bacterial infection syndromes.
Project Objectives:
◎ Completed Studies
| FLEMING FUND COUNTRY GRANT |
| GLOBAL GENOMIC AND PROTEOMIC PROFILING OF AFRICAN CHILDREN WITH TYPHOID FEVER |
IFAIN welcomes enquiries about research partnerships, co-investigator arrangements, and data access.